Diabetes technology use for management of type 1 diabetes is associated with fewer adverse covid-19 outcomes: findings from the T1D Exchange COVID-19 Surveillance Registry
Noor N, Ebekozien O, Levin L, et al.
Diabetes Care. 2021;dc210074.
Leggi
Noor N, Ebekozien O, Levin L, et al.
Diabetes Care. 2021;dc210074.
Leggi
Jacobson AM, Ryan CM, Braffett BH, et al.
Lancet Diabetes Endocrinol. 2021;9(7):436-445.
Leggi
Ceriello A
Diabetes Res Clin Pract. 2021;108864.
Leggi
Lamprea–Montealegre JA, Katz R, Scharnagl H, et al.
The American Journal of Cardiology. Pub. online 6 June 2021
Leggi
Karter AJ, Parker MM, Moffet HH, et al.
JAMA. 2021;325(22):2273-2284.
Leggi
Pylypchuk R, Wells S, Kerr A, et al.
The Lancet. Pub. online 2 June 2021
Leggi
Gastaldelli, A., Stefan, N. & Häring, HU
Diabetologia. 2021;64:1461-1479
Leggi
Benn M, Emanuelsson F, Tybjærg-Hansen A, et al.
Diabetologia. 2021;64:1492-1503
Leggi
Beulens JWJ, Yauw JS, Elders PJM, et al.
Diabetologia. 2021;64:1550-1562
Leggi
Li S, Vandvik PO, Lytvyn L, et al.
BMJ. 2021;373:n1091
Leggi